Soleno Therapeutics (SLNO) had the highest return between September 1, 2023 and December 31, 2023 by a US stock with a market cap of $2B+, returning 711.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 9/1/2023 - 12/31/2023 | 711.49% |
QXO (QXO) | 9/1/2023 - 12/31/2023 | 350.26% |
Immunitybio (IBRX) | 9/1/2023 - 12/31/2023 | 209.88% |
Scholar Rock (SRRK) | 9/1/2023 - 12/31/2023 | 200.32% |
Cytokinetics (CYTK) | 9/1/2023 - 12/31/2023 | 136.31% |
Affirm (AFRM) | 9/1/2023 - 12/31/2023 | 134.28% |
CleanSpark (CLSK) | 9/1/2023 - 12/31/2023 | 125.56% |
Ramaco Resources (METC) | 9/1/2023 - 12/31/2023 | 120.48% |
Coinbase Global (COIN) | 9/1/2023 - 12/31/2023 | 117.4% |
Bitfarms (BITF) | 9/1/2023 - 12/31/2023 | 112.41% |
Crinetics Pharmaceuticals (CRNX) | 9/1/2023 - 12/31/2023 | 103.31% |
Galaxy Digital (GLXY) | 9/1/2023 - 12/31/2023 | 103.1% |
Xometry (XMTR) | 9/1/2023 - 12/31/2023 | 86.06% |
Immunovant (IMVT) | 9/1/2023 - 12/31/2023 | 83.73% |
Gap (GAP) | 9/1/2023 - 12/31/2023 | 82.49% |
MicroStrategy (MSTR) | 9/1/2023 - 12/31/2023 | 76.66% |
Compania de Minas Buenaventura SAA ADR (BVN) | 9/1/2023 - 12/31/2023 | 76.39% |
Rhythm Pharmaceuticals (RYTM) | 9/1/2023 - 12/31/2023 | 75.06% |
TAL Education (TAL) | 9/1/2023 - 12/31/2023 | 72.78% |
Grindr (GRND) | 9/1/2023 - 12/31/2023 | 70.16% |
Macy’s (M) | 9/1/2023 - 12/31/2023 | 67.13% |
Alpha Metallurgical Resources (AMR) | 9/1/2023 - 12/31/2023 | 64.87% |
Companhia Siderurgica Nacional ADR (SID) | 9/1/2023 - 12/31/2023 | 64.09% |
HCI (HCI) | 9/1/2023 - 12/31/2023 | 63.88% |
Twist Bioscience (TWST) | 9/1/2023 - 12/31/2023 | 63.82% |
